UBS Group
RENEW

UBS Group’s Cartesian Growth Corporation II Warrant RENEW Stock Holding History

UBS Group’s Portfolio RENEW Stock Details RENEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-546
Closed -$55 – 9974
2024
Q2 		$55 Buy
+546
New +$60 ﹤0.01% 9224
2023
Q4 		– Sell
-38
Closed -$6 – 9788
2023
Q3 		$6 Buy
38
+37
+3,700% +$6 ﹤0.01% 9258
2023
Q2 		$0 Buy
+1
New – ﹤0.01% 9512

Other funds holding RENEW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $102M AUM 0.13% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

UBS Group's RENEW Position: Q3 2024 in Review

UBS Group sold out of Cartesian Growth Corporation II Warrant (RENEW) in Q3 2024, closing a stake of 546 shares — an estimated $55 sold.

UBS Group first reported a position in RENEW in Q2 2023 and held it in 3 quarters. The position peaked at $55 in Q2 2024. 27 funds tracked by Wall St. Rank hold RENEW as of Q3 2024.

  • UBS Group reported no remaining Cartesian Growth Corporation II Warrant position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 546 Cartesian Growth Corporation II Warrant shares in Q3 2024, an estimated $55.
  • UBS Group first reported a position in Cartesian Growth Corporation II Warrant in Q2 2023 and held it in 3 quarters.
  • UBS Group's Cartesian Growth Corporation II Warrant position peaked at $55 in Q2 2024.
  • 27 funds tracked by Wall St. Rank held Cartesian Growth Corporation II Warrant as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.